
Making One Health Better Biome for One Health
Making One Health Better Biome for One Health

건강하고 가치있는 원헬스 생태계를 만들고, 혁신적인 마이크로바이옴 치료제로 전 세계 환자의 삶을 변화시키 위해 설립된 브이원바이오(V1bio)는 건강한 동물로부터 유용 미생물을 발굴하여 항암 및 면역분야의 혁신적 생균 치료제 (LBP; Live Biotherapeutic Product)를 연구개발하고 있습니다.
브이원바이오는 지속 연구개발과 함께 독자적 연구 플랫폼 고도화로 개발파이프라인을 확보하고, 기술사업화 성공을 통하여, 보다 빠르게 글로벌 마이크로바이옴 치료제 신약개발 전문기업으로 성장하고자 합니다.
' Top-tier microbiome biotechnology company '
We are dedicated to pursuing groundbreaking microbiome to discover and develop medicines
Our mission is to provide the better lives of patients worldwide with revolutionary One Health microbiome and solutions
Respect for people, Act with intergrity
Communication with open-minded
Continuous challenge for innovation
One Health microbiome library
Microbiome profiling (AI & BI)
Multi-omics analysis, Translational research
Live biotherapeutic product (single strain)
Oncology, Immunology
One Health microbiome
Collaborative research
In-Iicensing
Out-licensing
One Health is at the intersection of human health, animal health, and environmental health. The structural and functional similarity of the dog microbiome to the human one implies that, as human studies are predictive of results in dogs, dog studies may be predictive of results in humans.
Our platform drives live biotherapeutic product candidate discovery and development and is the proprietary R&D platform in the microbiome area. We use VMPioneer to interrogate our extensive library of bacterial isolates to identify live biotherapeutic candidates for a targeted disease with a deep understanding of functionality, mechanism and the knowledge translation of research findings.
2022. 06. Expansion of research institute
2022. 05. Selection of venture company joint recruitment project participating company by the Ministry of SMEs and Startups
2022. 04. Selection of youth employment intern system participating company by the Ministry of Employment and Labor
2022. 03. Selection of KIT family company by the Korea Insitute of Toxicology
2022. 02. Selection of 2022 TIPS program by the Ministry of SMEs and Startups
2021. 12. Selection of K-STARTUP venture post-support program by the Ministry of SMEs and Startups
2021. 12. Certification of the company-affiliated research institute
2021. 11. Seed funding by the DAEWOONG Pharmaceuticals
2021. 11. Certification of the venture company
2021. 09. Seed funding by the Schmidt
2021. 05. Establishment of V1bio Inc
2021. 05. Patent application of microbe and its usage
2021. 04. Patent resource deposit of microbe
2020. 08. Selection of K-STARTUP venture program by the Ministry of SMEs and Startups
ONE HEALTH MICROBIOME TRANSFORMATION company
V1bio Inc. Room 708, B-dong, Songpa-daero 167, Songpa-gu, Seoul
COPYRIGHT©V1BIO INC., ALL RIGHTS RESERVED.
"창업진흥원 추천기업" 한국경제TV 혁신성장코리아 출연....